Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Logrank testing for GP88 score cut-off establishment in the training trial

From: Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma

GP88 scores DFS OS
Between Chi-squared P Chi-squared P
1 and 0 1.35 0.2459 2.06 0.1512
2 and 0, 1 0.21 0.6430 0.01 0.9159
3 and 0, 1, 2 17.07 0.00004 8.46 0.0036